Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
HDAC2 (human)
p Phosphorylation
a Acetylation
m Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
u Ubiquitination
s Sumoylation
n Neddylation
g O-GlcNAc
h Palmitoylation
ad Adenylylation
sn S-Nitrosylation
ca Caspase cleavage

Overview
HDAC2 a transcriptional regulator of the histone deacetylase family, subfamily 1. Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation plays a role in epigenetic repression and transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Note: This description may include information from UniProtKB.
Protein type: EC 3.5.1.98; Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Deacetylase
Cellular Component: nucleoplasm; heterochromatin; transcription factor complex; Sin3 complex; ESC/E(Z) complex; cytoplasm; replication fork; NuRD complex; nucleus
Molecular Function: protein binding; NAD-dependent histone deacetylase activity (H3-K9 specific); enzyme binding; NAD-dependent histone deacetylase activity (H3-K14 specific); sequence-specific DNA binding; chromatin DNA binding; protein deacetylase activity; chromatin binding; NAD-dependent histone deacetylase activity (H4-K16 specific); histone deacetylase activity; transcription factor binding; transcription factor activity
Biological Process: transcription, DNA-dependent; nerve growth factor receptor signaling pathway; positive regulation of proteolysis; positive regulation of transcription, DNA-dependent; negative regulation of transcription factor activity; hippocampus development; positive regulation of collagen biosynthetic process; histone deacetylation; negative regulation of transcription from RNA polymerase II promoter; odontogenesis of dentine-containing teeth; negative regulation of cell cycle; chromatin remodeling; positive regulation of cell proliferation; maintenance of chromatin silencing; dendrite development; negative regulation of MHC class II biosynthetic process; epidermal cell differentiation; positive regulation of transcription from RNA polymerase II promoter; embryonic digit morphogenesis; positive regulation of oligodendrocyte differentiation; negative regulation of transcription, DNA-dependent; blood coagulation; negative regulation of apoptosis
Reference #:  Q92769 (UniProtKB)
Alt. Names/Synonyms: HD2; HDAC2; Histone deacetylase 2; RPD3; transcriptional regulator homolog RPD3; YAF1; YY1-associated factor 1
Gene Symbols: HDAC2
Molecular weight: 55,364 Da
Basal Isoelectric point: 5.59  Predict pI for various phosphorylation states
CST Pathways:  Cell Cycle: G1/S Checkpoint  |  NF-kB Signaling  |  Protein Acetylation  |  Wnt/ß-Catenin Signaling
Protein-Specific Antibodies or siRNAs from Cell Signaling Technology® Total Proteins
Select Structure to View Below

HDAC2

Protein Structure Not Found.


STRING  |  Scansite  |  Phospho.ELM  |  NetworKIN  |  Pfam  |  RCSB PDB  |  ENZYME  |  Phospho3D  |  DISEASE  |  Source  |  NURSA  |  UCSD-Nature  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene


Sites Implicated In
acetylation: S394‑p, S411‑p, S422‑p, S424‑p
enzymatic activity, induced: S394‑p
enzymatic activity, inhibited: S394‑p, S411‑p, S422‑p, S424‑p
molecular association, regulation: S394‑p, S411‑p, S422‑p, S424‑p

Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 1 Y3-p _____MAySQGGGKK
0 1 S4 ____MAySQGGGKKk
0 1 K11-u SQGGGKKkVCYYYDG
0 1 Y49-p LLLNYGLyRKMEIYR
0 2 K67-u ATAEEMTkYHSDEYI
0 1 K75-a YHSDEYIkFLRSIRP
0 3 K75-u YHSDEYIkFLRSIRP
0 8 Y88-p RPDNMSEySkQMQRF
0 75 K90-u DNMSEySkQMQRFNV
0 2 Y222-p IGAGKGKyYAVNFPM
0 15 K243-u ESYGQIFkPIISkVM
0 1 K248-u IFkPIISkVMEMYQP
0 1 S349 FKLHISPSNMTNQNT
0 1 T352 HISPSNMTNQNTPEy
0 1 T356 SNMTNQNTPEyMEkI
0 2 Y359-p TNQNTPEyMEkIKQR
0 1 K362-u NTPEyMEkIKQRLFE
3 82 S394-p EDAVHEDsGDEDGED
0 5 S407-p EDPDKRIsIRAsDKR
2 0 S411-p KRIsIRAsDKRIACD
2 60 S422-p IACDEEFsDsEDEGE
3 59 S424-p CDEEFsDsEDEGEGG
1 0 K462-s EDKKTDVkEEDKSKD
0 1 T477-p NSGEKTDtKGTKSEQ
  mouse

 
Y3 _____MAYsQGGGKK
S4-p ____MAYsQGGGKKK
K11 sQGGGKKKVCYYYDG
Y49 LLLNYGLYRKMEIYR
K67 ATAEEMTKYHSDEYI
K75 YHSDEYIKFLRSIRP
K75-u YHSDEYIkFLRSIRP
Y88-p RPDNMSEySkQMQRF
K90-u DNMSEySkQMQRFNV
Y222 IGAGKGKYYAVNFPM
K243-u ESYGQIFkPIISKVM
K248 IFkPIISKVMEMYQP
S349-p FKLHISPsNMtNQNt
T352-p HISPsNMtNQNtPEy
T356-p sNMtNQNtPEyMEKI
Y359-p tNQNtPEyMEKIKQR
K362 NtPEyMEKIKQRLFE
S394-p EDAVHEDsGDEDGED
S407 EDPDKRISIRAsDKR
S411-p KRISIRAsDKRIACD
S422-p IACDEEFsDsEDEGE
S424-p CDEEFsDsEDEGEGG
K462 EDKKTDVKEEDKSKD
P477 NSGEKTDPKGAKSEQ
  rat

 
- gap
- gap
- gap
- gap
- gap
- gap
- gap
- gap
- gap
- gap
- gap
- gap
S35 FKLHISPSNMTNQNT
T38 HISPSNMTNQNTPEY
T42 SNMTNQNTPEYMEKI
Y45 TNQNTPEYMEKIKQR
K48 NTPEYMEKIKQRLFE
S80 EDAVHEDSGDEDGED
S93 EDPDKRISIRASDKR
S97 KRISIRASDKRIACD
S108-p IACDEEFsDsEDEGE
S110-p CDEEFsDsEDEGEGG
K148 EDKKTDVKEEDKSKD
T163 NSGEKTDTKGAKSEQ
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.